FDA approves weight-loss drug Zepbound to treat sleep apnea
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
A woman who lost 100 pounds on semaglutide shared 3 ways the holiday season has changed — including not feeling the need to diet in the new year
At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...
Psychology Today6d
Three Ways New Weight Loss Drugs May Improve Depression
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Yahoo7d
FDA approves weight-loss drug Zepbound to treat sleep apnea
Photo courtesy Eli Lilly & Co. Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co ... medications more than doubled between 2022 and 2023. Meanwhile, they have also ...
US obesity rates drop for 1st time in a decade, with possible help from weight loss medications
Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the South, where they had the highest dispensing rate of weight loss drugs ...
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.
Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025
Not just Tirzepatide, the company plans to launch multiple newly developed products from its global portfolio in the Indian ...
US obesity rates drop for the first time in a decade likely due to popular weight loss medications
The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...
Ars Technica17d
Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
“The weight loss attributes of the drugs are responsible for most of the benefits in multiple diseases, or are the ...
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...